Medication info
Mericl M Tablet 2/500mg

Mericl M Tablet 2/500mg

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
Domestic: 30 tablets/bottle, 300 tablets/bottle, Export: 30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201106980 · Approved 2011.09.23

Summary

Main use
Improves glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted considering the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there was experience with gradually increasing the dose according to blood glucose monitoring results, up to glimepiride/metformin hydrochloride 8mg/2000mg. As a single agent, glimepiride generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Improves glycemic control in type 2 diabetes mellitus

View approved original text

This medication helps patients with type 2 diabetes who have difficulty controlling blood sugar levels through diet and exercise alone. The two ingredients, glimepiride and metformin, work together to lower blood sugar levels and improve blood sugar control. This helps facilitate better management of blood sugar levels. When used in conjunction with diet and exercise, the blood sugar control effect can be enhanced. This medication plays an important role in improving blood sugar control and assisting in diabetes management.

How to take

Adult dose

Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted considering the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there was experience with gradually increasing the dose according to blood glucose monitoring results, up to glimepiride/metformin hydrochloride 8mg/2000mg. As a single agent, glimepiride generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Precautions

This medication may pose a risk of severe lactic acidosis or hypoglycemia, therefore, if there is a rapid decline in kidney function or symptoms of dehydration, use should be temporarily halted and you should consult a physician. Use is contraindicated for patients with kidney function below 45 mL/min/1.73 m², and caution is required when used with drugs that can cause changes in kidney function. Additionally, because it may increase the risk of cardiovascular diseases, it is crucial to discuss the risks and benefits of this medication with your healthcare provider in relation to other treatments. It should not be administered to certain patient populations, including those with insulin-dependent diabetes, severe liver dysfunction, pregnant or breastfeeding women, and those with severe kidney impairment. For patients or situations at high risk of hypoglycemia, careful monitoring is needed from the beginning of treatment. Irregular eating, intense exercise, and alcohol consumption may increase the risk of hypoglycemia. This medication may cause gastrointestinal symptoms (such as diarrhea, vomiting, abdominal pain), but these are typically transient and can be alleviated by taking it with meals or gradually increasing the dosage. Rarely, allergic reactions, blood abnormalities, vitamin B12 deficiency, and liver function abnormalities may occur, so if any unusual symptoms arise, contact a doctor immediately. During treatment, regular monitoring of blood sugar, kidney function, and blood tests should be conducted, especially in the elderly, who should be cautious of declining kidney function. Because this medication can interact with other drugs, consult your healthcare provider before starting or stopping any new medications. Pregnant or breastfeeding women should not use this medication; switching to insulin therapy for blood sugar control is recommended. Safety in children and adolescents has not been sufficiently established, therefore extra caution is advised when prescribing to minors. In the event of an overdose, severe hypoglycemia or lactic acidosis may occur, so if symptoms appear, seek appropriate medical care immediately. This medication does not cause weight gain and is beneficial in maintaining blood sugar control and reducing the risk of diabetes complications with long-term use. Caution is advised when driving or operating machinery as symptoms such as hypoglycemia or dizziness may occur.

Side effects

  • Uterine contractions
  • hypoglycemia
  • diarrhea
  • nausea
  • vomiting
  • abdominal bloating
  • loss of appetite
  • indigestion
  • constipation
  • abdominal pain
Show 46 more
  • metallic taste
  • visual impairment
  • taste disorder
  • erythema
  • itching
  • urticaria
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • erythropenia
  • agranulocytosis
  • pancytopenia
  • vitamin B12 deficiency
  • peripheral neuropathy
  • macrocytic anemia
  • increased liver enzymes
  • liver dysfunction
  • cholestasis
  • jaundice
  • hepatitis
  • allergic vasculitis
  • photoallergic dermatitis
  • decreased serum sodium concentration
  • hypothyroidism
  • magnesium deficiency during diarrhea
  • encephalopathy
  • hair loss
  • weight gain
  • abdominal pain
  • abdominal bloating
  • vomiting
  • indigestion
  • palpitations
  • dizziness
  • diarrhea
  • nausea
  • leg edema
  • cardiac arrest
  • rectal cancer
  • dizziness
  • liver dysfunction
  • arthralgia
  • facial swelling
  • erectile dysfunction
  • facial flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air exposure and kept at a temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness and prevents degradation.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

Domestic: 30 tablets/bottle, 300 tablets/bottle, Export: 30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.